WELLS FARGO & COMPANY/MN - ADAMIS PHARMACEUTICALS CORP ownership

ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 49 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q1 2023. The put-call ratio across all filers is 0.08 and the average weighting 0.0%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of ADAMIS PHARMACEUTICALS CORP
ValueSharesWeighting
Q1 2023$1,279
+639.3%
11,037
+981.0%
0.00%
Q4 2022$1731,021
+2.5%
0.00%
Q3 2022$0
-100.0%
996
-0.6%
0.00%
Q2 2022$1,0000.0%1,002
+9.4%
0.00%
Q1 2022$1,0000.0%916
+0.3%
0.00%
Q4 2021$1,0000.0%9130.0%0.00%
Q3 2021$1,0000.0%913
-4.7%
0.00%
Q2 2021$1,0000.0%958
+10.1%
0.00%
Q1 2021$1,000870
+42.6%
0.00%
Q4 2020$0610
+34.7%
0.00%
Q3 2020$0453
-8.3%
0.00%
Q2 2020$0494
+19.9%
0.00%
Q1 2020$0
-100.0%
412
-78.1%
0.00%
Q4 2019$1,000
-97.4%
1,881
-96.6%
0.00%
Q3 2019$39,000
-47.3%
54,975
-3.3%
0.00%
Q2 2019$74,000
-31.5%
56,878
+10.8%
0.00%
Q1 2019$108,000
-10.7%
51,328
-4.3%
0.00%
Q4 2018$121,000
+10.0%
53,662
+70.8%
0.00%
Q3 2018$110,000
-8.3%
31,414
-15.8%
0.00%
Q2 2018$120,000
+22.4%
37,290
+32.6%
0.00%
Q1 2018$98,000
-21.0%
28,128
-0.2%
0.00%
Q4 2017$124,000
+853.8%
28,182
+1050.3%
0.00%
Q3 2017$13,000
-92.3%
2,450
-92.5%
0.00%
Q2 2017$169,000
+1777.8%
32,500
+983.3%
0.00%
Q4 2016$9,000
+800.0%
3,000
+1363.4%
0.00%
Q4 2014$1,0002050.00%
Other shareholders
ADAMIS PHARMACEUTICALS CORP shareholders Q1 2023
NameSharesValueWeighting ↓
Capital CS Group, LLC 75,669$38,0000.04%
Founders Capital Management 18,000$9,0000.01%
Verdence Capital Advisors LLC 58,382$29,0000.00%
WOLFF WIESE MAGANA LLC 10,740$5,0000.00%
TWO SIGMA SECURITIES, LLC 93,669$47,0000.00%
Affinity Capital Advisors, LLC 13,180$7,0000.00%
Tower Research Capital LLC (TRC) 171,928$86,0000.00%
B. Riley Wealth Advisors, Inc. 25,210$13,0000.00%
EDMOND DE ROTHSCHILD HOLDING S.A. 100,000$50,0000.00%
MGO ONE SEVEN LLC 10,615$5,0000.00%
View complete list of ADAMIS PHARMACEUTICALS CORP shareholders